A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol

• Autori principali: Sophia I. Allen (Autore), Jonathan Foulds (Autore), Gladys N. Pachas (Autore), Susan Veldheer (Autore), Corinne Cather (Autore), Nour Azzouz (Autore), Shari Hrabovsky (Autore), Ahmad Hameed (Autore), Jessica Yingst (Autore), Erin Hammett (Autore), Jennifer Modesto (Autore), Nicolle M. Krebs (Autore), Junjia Zhu (Autore), Jason Liao (Autore), Joshua E. Muscat (Autore), John Richie (Autore), A. Eden Evins (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2017-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background The U.S. Food and Drug Administration can set standards for cigarettes that could include reducing their nicotine content. Such a standard should improve public health without causing unintended serious consequences for sub-populations. This study evaluates the effect of progress...